Cancer Prevention Program

Genome-Wide Association Study on Breast Cancer within the Women's Health Initiative

PI: Ross Prentice PhD

This study seeks to identify aspects of genotype that relate to the risk of breast and colorectal cancer, and aspects of genotype that relate to the magnitude of intervention effects on breast and colorectal cancer in the Women's Health Initiative (WHI) randomized controlled clinical trial (CT). This study involves an ongoing genome-wide scan of breast cancer cases (as well as coronary heart diasease and stroke cases) and matched controls in the WHI cohorts, being carried out as a collaborative study between Perlegen Sciences and the WHI.